KM Research Hub
← 返回结果库查看论文详情PubMed ↗
READ-ONLY DIGITIZATION RESULT

A phase 3 study of intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.

Blood · 2026-Apr-09 · PMID 41490515

Panel D_8提取完成待 EXE 对齐验证

EFS

Figure 3. Prespecified subgroup analyses for the primary end point EFS by treatment arm and according to patient subgroups. (A) According to KIT mutation status, mutated vs wt. (B) According to type of CBF-AML, inv(16) vs t(8;21). (C) According to age group, 18 to 60 years vs >60 years. (D) According to sex, male vs female.

算法:legacy-0.5.0引擎:enhanced-linux
质量评分0.58
质量通过是
预期曲线2
实际曲线2
X 范围1 – 10
Y 范围-

曲线数据

网页最多预览 200 行,完整数据请下载 CSV 或 JSON。

匹配 31 行
Curve序号X (norm)Y (norm)X (real)Y (real)X (pixel)Y (pixel)
110.00000.27451.00007437
120.05000.27451.00008737
130.05380.27451.00008837
140.05770.27451.00008937
150.06150.27451.00009037
160.06540.27451.00009137
170.06920.29411.00009236
180.09620.25491.00009938
190.10000.25491.000010038
1100.10380.25491.000010138
1110.10770.25491.000010238
1120.11150.25491.000010338
1130.11540.25491.000010438
1140.11920.25491.000010538
1150.16150.25491.122711638
1160.17310.25491.245511938
1170.17690.25491.286412038
1180.18080.25491.327312138
1190.18850.21571.409112340
1200.19230.21571.450012440
1210.20380.21571.572712740
1220.20770.21571.613612840
210.00000.23531.00007439
220.16920.23531.204511839
230.17310.23531.245511939
240.17690.23531.286412039
250.18080.23531.327312139
260.18460.23531.368212239
270.18850.23531.409112339
280.19230.23531.450012439
290.19620.23531.490912539
历史版本(1)

重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。

版本状态验证曲线时间
legacy-0.5.0complete待验证22026-07-23T17:00:12+00:00